Citizens Maintains Market Outperform on Pharvaris, Lowers Price Target to $74

Pharvaris N.V.

Pharvaris N.V.

PHVS

0.00

Citizens analyst Jonathan Wolleben maintains Pharvaris (NASDAQ: PHVS) with a Market Outperform and lowers the price target from $75 to $74.